4.6 Article

An m6A-Driven Prognostic Marker Panel for Renal Cell Carcinoma Based on the First Transcriptome-Wide m6A-seq

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

METTL3 is essential for normal progesterone signaling during embryo implantation via m(6)A-mediated translation control of progesterone receptor

Zhan-Hong Zheng et al.

Summary: m(6)A modification plays a crucial role in embryo implantation by maintaining P-4 signaling. METTL3 enhances the translation efficiency of PGR protein by modifying Pgr mRNA with m(6)A, thereby affecting the process of embryo implantation.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Review Pharmacology & Pharmacy

RNA N6-methyladenosine modifications and potential targeted therapeutic strategies in kidney disease

Wei-Jian Ni et al.

Summary: This review comprehensively discusses the crucial roles of N-6-methyladenosine (m(6)A), the most common RNA modification, in kidney diseases. It also explores the possibilities and relevance of using m(6)A as a target for epigenetic therapy and provides a detailed description of the specific alterations in loci associated with cellular processes related to kidney diseases.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Medicine, General & Internal

Upregulation of C/EBP Homologous Protein induced by ER Stress Mediates Epithelial to Myofibroblast Transformation in ADTKD-UMOD

Dan Wang et al.

Summary: ADTKD-UMOD caused by UMOD mutations results in chronic interstitial nephritis, possibly through specific activation of CHOP in renal tubular epithelial cells induced by UMOD protein, leading to renal interstitial fibrosis.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2022)

Article Cell Biology

Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms

Jia-Nan Wang et al.

Summary: The role of N-6-methyladenosine (m6A) modifications in renal diseases, particularly acute kidney injury (AKI), is still largely unknown. In this study, the researchers investigated the role of N-6-adenosine-methyltransferase-like 3 (METTL3) in AKI and found that its expression is elevated in renal tubules. They discovered that silencing METTL3 alleviated renal inflammation and programmed cell death in tubular epithelial cells (TECs) in response to stimulation, while overexpression of METTL3 had the opposite effects. Conditional knockout of METTL3 in mice also attenuated renal dysfunction, injury, and inflammation induced by AKI. Furthermore, the researchers identified TAB3 as a target of METTL3 and explored its proinflammatory effects. They also investigated the therapeutic potential of inhibiting METTL3 using an inhibitor called Cpd-564. Overall, they concluded that the METTL3/TAB3 axis may be a potential target for the treatment of AKI.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Oncology

Molecular subtypes of m6A RNA methylation modification patterns and their clinical significance in clear cell renal cell carcinoma

Bo Guan et al.

Summary: This study investigated the association between N6-methyladenosine (m6A) RNA methylation-modification patterns and patient prognosis in clear cell renal cell carcinoma (ccRCC), and constructed a ccRCC molecular signature based on expressions of m6A-related genes. The results showed that m6A RNA methylation modification may serve as a potential therapeutic target and play a crucial role in ccRCC, as the different molecular subtypes of ccRCC based on m6A RNA methylation patterns were found to have different prognoses.

TRANSLATIONAL CANCER RESEARCH (2022)

Article Oncology

NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2

Decai Wang et al.

Summary: Bladder cancer is a common malignant tumor of the urinary system, and chemotherapy resistance is a major challenge in its treatment. This study identifies NXPH4 as a novel molecule that plays a role in bladder cancer by affecting cancer cell proliferation, migration, invasion, glycolysis, and gemcitabine resistance. The findings suggest that NXPH4 may provide a new therapeutic angle for bladder cancer.

CANCERS (2022)

Article Medicine, Research & Experimental

Comprehensive RNA-seq reveals molecular changes in kidney malignancy among people living with HIV

Juan Bao et al.

Summary: In this study, differentially expressed mRNAs in HIV-associated kidney cancer were analyzed using RNA sequencing to increase awareness and facilitate early diagnosis. The results showed similar findings to renal cell carcinoma in the general population. The pathway analysis revealed important pathways related to kidney malignancy. These findings provide insights into cancer progression and offer potential therapeutic approaches for PLWH.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Oncology

NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer

Zhiming Gui et al.

Summary: This study evaluated the immune gene score of MIBC data in TCGA and GEO databases using GSVA and successfully constructed a LASSO Cox expression model. Patients in the high-risk group had a worse prognosis and were more sensitive to immunotherapy. PD-1 inhibitors or PD-1 combined with CTLA-4 inhibitors can be preferentially used in high-risk patients.

JOURNAL OF ONCOLOGY (2022)

Article Biotechnology & Applied Microbiology

Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer

Xianchao Sun et al.

Summary: Recent studies have found that NXPH family member 4 (NXPH4) plays a crucial role in cancer progression and could serve as a biomarker for predicting the prognosis of bladder cancer (BCa). NXPH4 is highly expressed in BCa tissues and is associated with shorter overall survival and progression-free survival. It is also involved in immune-related pathways and immune cell infiltration in BCa. The proliferative effect of NXPH4 has been confirmed in both in vitro and in vivo BCa models.

BIOENGINEERED (2022)

Review Physiology

Uromodulin: Roles in Health and Disease

Celine Schaeffer et al.

Summary: Uromodulin, a kidney-specific protein, plays crucial roles in kidney physiology and overall health, with its genetic mutations causing renal disease and common polymorphisms associated with various disorders such as chronic kidney disease, hypertension, and cardiovascular diseases. Variations in uromodulin levels in urine and blood can serve as prognostic markers for kidney function, cardiovascular events, and mortality.

ANNUAL REVIEW OF PHYSIOLOGY, VOL 83 (2021)

Article Multidisciplinary Sciences

Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia

Eliza Yankova et al.

Summary: The study identified a highly potent and selective catalytic inhibitor of METTL3, STM2457, which shows potential therapeutic value in treating AML. Treatment with this inhibitor leads to reduced AML growth, increased differentiation and apoptosis, and decreased m(6)A levels on leukemogenic mRNAs. In vivo pharmacological inhibition of METTL3 results in impaired engraftment and prolonged survival in mouse models of AML.

NATURE (2021)

Review Biochemistry & Molecular Biology

A comprehensive review of m6A/m6Am RNA methyltransferase structures

Stephanie Oerum et al.

Summary: Gene expression is regulated through various levels, including chemical modifications on RNA during or after transcription. One such modification is N6-methylation, which affects the structure, stability, degradation, and cellular interactions of the modified RNA, with dysregulation linked to multiple human cancers.RNA methyltransferases are the enzymes responsible for these modifications, and structural characterization of these enzymes is critical for understanding their functions.

NUCLEIC ACIDS RESEARCH (2021)

Article Cell Biology

EGR2-mediated regulation of m6A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization

Yufan Ying et al.

Summary: In renal cell cancer, IGF2BPs regulate the expression of S1PR3 in an m(6)A-dependent manner and promote kidney tumorigenesis by enhancing the stability of S1PR3 mRNA. Upregulation of IGF2BPs and WTAP in RCC predicts poor overall survival.

CELL DEATH & DISEASE (2021)

Review Biochemistry & Molecular Biology

The role of m6A modification in the biological functions and diseases

Xiulin Jiang et al.

Summary: This paper highlights the importance of m6A RNA modification in eukaryotic RNA, including the roles of m6A methyltransferases, demethylases, and binding proteins. It emphasizes the crucial role of m6A RNA modification in the development of human cancers and discusses its impact on the physiological and pathological progressions of hematopoietic, central nervous, and reproductive systems.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Genetics & Heredity

The epitranscriptome beyond m6A

David Wiener et al.

Summary: This Perspective reviews efforts to map six different RNA modifications and how they differ from N-6-methyladenosine. The authors discuss technical and analytical challenges of characterizing the epitranscriptome and provide their conclusions on the abundance and distribution of these modifications. The article highlights commonalities and differences among the modifications in comparison to m(6)A, speculating on their origins and functional abilities over evolutionary timescales.

NATURE REVIEWS GENETICS (2021)

Review Urology & Nephrology

Epidemiology of Renal Cell Carcinoma

Umberto Capitanio et al.

EUROPEAN UROLOGY (2019)

Article Medicine, General & Internal

Autosomal dominant tubulointerstitial kidney disease

Olivier Devuyst et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Review Biochemistry & Molecular Biology

Functions of N6-methyladenosine and its role in cancer

Liuer He et al.

MOLECULAR CANCER (2019)

Editorial Material Multidisciplinary Sciences

dLimited antibody specificity compromises epitranscriptomic analyses

Mark Helm et al.

NATURE COMMUNICATIONS (2019)

Review Biotechnology & Applied Microbiology

Link Between m6A Modification and Cancers

Zhen-Xian Liu et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2018)

Review Cell Biology

Translating the epitranscriptome

Thomas Philipp Hoernes et al.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2017)

Review Genetics & Heredity

Detecting RNA modifications in the epitranscriptome: predict and validate

Mark Helm et al.

NATURE REVIEWS GENETICS (2017)

Article Biochemistry & Molecular Biology

RNA fate determination through cotranscriptional adenosine methylation and microprocessor binding

Philip Knuckles et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)

Article Biochemistry & Molecular Biology

RNA fate determination through cotranscriptional adenosine methylation and microprocessor binding

Philip Knuckles et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)

Article Urology & Nephrology

Associations of Urinary Uromodulin with Clinical Characteristics and Markers of Tubular Function in the General Population

Menno Pruijm et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Editorial Material Biochemistry & Molecular Biology

N6-methyladenosine-encoded epitranscriptomics

Nian Liu et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)

Review Genetics & Heredity

Update: Mechanisms Underlying N6-Methyladenosine Modification of Eukaryotic mRNA

Yang Wang et al.

TRENDS IN GENETICS (2016)

Editorial Material Biochemistry & Molecular Biology

N6-methyladenosine-encoded epitranscriptomics

Nian Liu et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)

Article Biochemistry & Molecular Biology

HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events

Claudio R. Alarcon et al.

Article Biochemistry & Molecular Biology

N6-methyladenosine Modulates Messenger RNA Translation Efficiency

Xiao Wang et al.

Article Biochemical Research Methods

Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome

Bastian Linder et al.

NATURE METHODS (2015)

Article Multidisciplinary Sciences

Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq

Dan Dominissini et al.

NATURE (2012)

Article Biochemistry & Molecular Biology

A transcriptional network in polycystic kidney disease

L Gresh et al.

EMBO JOURNAL (2004)